The MoU for the joint venture was signed here today by the visiting South African president Thabo Mbeki himself.
This makes BBIL the first Indian company in the area of pharmaceuticals and biotechnology to enter South Africa as manufacturing collaborator.
Mvelaphanda, and the Industrial Development Cooperation of South Africa would have equity participation in the proposed Indo-South African venture with a holding for BBIL.
